Stryker Corporation CEO Weighs In On Q2 Earnings And Muka Metal Acquisition

Loading...
Loading...

Medical technology company Stryker Corporation SYK came out with better than expected second-quarter numbers on Thursday post market closing. The company also raised its 2015 sales growth guidance to 6.5–7.5 percent from 6–7 percent earlier.

Kevin Lobo, Stryker chairman and CEO, was on CNBC Friday to weigh in on the earnings and discuss the recent acquisition of Muka Metal.

Still Reporting Positive Growth

"Our organic sales were up 7 percent, so, very strong," Lobo began. "If you include currency, it was about 3 percent. So, we still have a positive growth, which many companies that are reporting have negative total growth. So, our U.S. business grew over 9 percent, which was tremendous growth. Our international business grew about 4 percent on an organic basis."

Related Link: How The $54.2 Billion Anthem-Cigna Deal Benefits Both Companies

Muka Metal Acqusition

On the Muka Metal acquisition Lobo said, "It's a bed and structure company. In Turkey, they have a state of the art facility and they provide products that are a little bit lower priced than our Mainland Stryker products. We had a joint venture with them and we were selling their beds in Brazil."

Lobo dismissed the possibility of using Muka Metal to branch out to manufacturing other things apart from beds and structures, saying, "Well, for now we are going to focus really on beds and structures. That's one of our strong divisions, is our medical division, which is growing close to 20 percent the last four quarters. So, a very strong performing business for us that we sell globally. But, obviously transporting a bed from the United States will cost a lot. So, having local manufacturing really does help us."

Image Credit: Public Domain
Loading...
Loading...
Posted In: CNBCHealth CareMediaChinaKevin LoboMuka MetalorthopedicsTurkey
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...